These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34501703)

  • 1. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
    Lofters A; Devotta K; Prakash V; Vahabi M
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
    Devotta K; Vahabi M; Prakash V; Lofters A
    BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a Cervical Cancer Screening Intervention for Under- or Never-Screened Women in Ontario, Canada: Understanding the Acceptability of HPV Self-Sampling.
    Devotta K; Vahabi M; Prakash V; Lofters AK
    Curr Oncol; 2023 Jul; 30(7):6786-6804. PubMed ID: 37504357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 6. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
    Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model.
    Dutton T; Marjoram J; Burgess S; Montgomery L; Vail A; Callan N; Jacob S; Hawkes D; Saville M; Bailey J
    BMC Health Serv Res; 2020 May; 20(1):398. PubMed ID: 32393243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
    Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
    BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
    Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
    BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience and acceptability for HPV self-sampling among women in Jiangsu province, China: a cross-sectional survey.
    Qu SX; Ni YH; Qin JF; Chen XY; Wu WL; Zhang WC
    J Obstet Gynaecol; 2023 Dec; 43(1):2204942. PubMed ID: 37129887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
    Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A
    BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
    Brandt T; Wubneh SB; Handebo S; Debalkie G; Ayanaw Y; Alemu K; Jede F; von Knebel Doeberitz M; Bussmann H
    BMC Public Health; 2019 Jul; 19(1):1026. PubMed ID: 31366402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.